Meridian Bioscience Comments on Recent FDA Matters Related to Magellan Diagnostics
June 30, 2017 12:02 ET
|
Meridian Bioscience, Inc.
CINCINNATI, June 30, 2017 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ:VIVO). Meridian Bioscience, Inc. is providing the following clarifying comments regarding a June 29, 2017 letter from...
Meridian Bioscience, Inc. Expects to Report Third Quarter Fiscal 2017 Operating Results on Thursday, July 27, 2017
June 28, 2017 09:00 ET
|
Meridian Bioscience, Inc.
CINCINNATI, June 28, 2017 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ:VIVO), a leading diagnostic and life science component company, expects to release its third quarter fiscal 2017...
Meridian Bioscience Comments on Recent FDA Posting Related to Magellan Diagnostics
June 06, 2017 14:25 ET
|
Meridian Bioscience, Inc.
CINCINNATI, June 06, 2017 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ:VIVO). Meridian Bioscience, Inc. is providing the following clarifying comments on the FDA’s recent recall...
Meridian Bioscience Comments on FDA Matter Involving its Subsidiary, Magellan Diagnostics
May 17, 2017 15:30 ET
|
Meridian Bioscience, Inc.
CINCINNATI, May 17, 2017 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ:VIVO). Meridian Bioscience, Inc.’s subsidiary, Magellan Diagnostics, Inc., is currently working with the U.S....
Meridian Bioscience Engages Korn Ferry to Conduct CEO Search as John A. Kraeutler Announces Plans to Retire
May 10, 2017 09:00 ET
|
Meridian Bioscience, Inc.
CINCINNATI, May 10, 2017 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ:VIVO) today announced it will commence a global search for a new Chief Executive Officer in conjunction with the...
Magellan Diagnostics (Meridian Bioscience, Inc., NASDAQ: VIVO) Launches National Education Initiative on Risks of Lead Exposure for Pregnant Women
May 09, 2017 09:00 ET
|
Meridian Bioscience, Inc.
CINCINNATI, May 09, 2017 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ:VIVO) announced today that Magellan Diagnostics Inc., a business unit of Meridian, has embarked on a major new...
Meridian Continues Its Fight Against Tropical Diseases by Introducing the Most Comprehensive Menu of Antigens and Antibodies for Diagnostic Applications
May 04, 2017 10:03 ET
|
Meridian Bioscience, Inc.
CINCINNATI, May 04, 2017 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ:VIVO) today announced the most comprehensive product offering of tropical disease biologicals intended for the...
Meridian Bioscience Reports Second Quarter 2017 Operating Results, Declares Regular Cash Dividend, and Reaffirms Fiscal 2017 Guidance
April 27, 2017 07:45 ET
|
Meridian Bioscience, Inc.
GENERAL HIGHLIGHTS CINCINNATI, April 27, 2017 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ:VIVO) today: reported fiscal 2017 second quarter and first six months net revenues of $54.1 and...
Prosedur Pengujian Baru Berpotensi Besar Menjadi Alat Penting dalam Upaya Global untuk Memberantas Malaria
April 24, 2017 09:56 ET
|
Meridian Bioscience, Inc.
CINCINNATI, April 24, 2017 (GLOBE NEWSWIRE) -- Saat komunitas global berkumpul pada Hari Malaria Sedunia untuk merayakan keberhasilan dan merencanakan strategi memberantas penyakit ini dari...
Nuevo procedimiento de prueba promete ser una herramienta crucial en el esfuerzo global para eliminar el paludismo
April 24, 2017 09:56 ET
|
Meridian Bioscience, Inc.
CINCINNATI, April 24, 2017 (GLOBE NEWSWIRE) -- Mientras la comunidad global se reúne en el Día Mundial del Paludismo para celebrar los éxitos y el plan estratégico para eliminar la enfermedad de la...